EUVIMEDEUVIMED entdecken
Crossref

The evolution and interpretation of seroprevalence of SARS‐CoV ‐2 antibodies among South African blood donors from the Beta to Omicron variant‐driven waves

Marion Vermeulen iD, Laurette Mhlanga, Wendy Sykes, Russell Cable, Charl Coleman, Nadia Pietersen, Ronel Swanevelder, Tanya Nadia Glatt iD, Jeremy Bingham, Karin van den Berg iD, Eduard Grebe, Alex Welte

Vox Sanguinis · 2024

DOI: 10.1111/vox.13571 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vox Sanguinis, 2024. Verfasst von Marion Vermeulen und 11 weiteren Autor:innen. Beteiligte Einrichtung: South African National Blood Service, Johannesburg, South Africa. Hauptthemen laut MEDLINE: Blood Donors, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Centre of Excellence grant from the South African Department of Science and Innovation via the National Research Foundation, NIH Fogarty International Center training, South African National Blood Service and the Western Cape Blood Service, ELMA South Africa Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Confirmed COVID‐19 diagnoses underestimate the total number of infections. Blood donors can provide representative seroprevalence estimates, which can be leveraged into reasonable estimates of total infection counts and infection fatality rate (IFR). Materials and Methods Blood donors who donated after each of three epidemic waves (Beta, Delta and first Omicron waves) were tested for anti‐SARS‐CoV‐2 nucleocapsid antibodies using the Roche Elecsys anti‐SARS‐CoV‐2 total immunoglobulin assay. Roche Elecsys anti‐spike antibody testing was done for the post‐Omicron sampling. Prevalence of antibodies was estimated by age, sex, race and province and compared to official case reporting. Province and age group‐specific IFRs were estimated using external excess mortality estimates.

Results

The nationally weighted anti‐nucleocapsid seroprevalence estimates after the Beta, Delta and Omicron waves were 47% (46.2%–48.6%), 71% (68.8%–73.5%) and 87% (85.5%–88.4%), respectively. There was no variation by age and sex, but there were statistically and epidemiologically significant differences by province (except at the latest time point) and race. There was a 13‐fold higher seroprevalence than confirmed case counts at the first time point. Age‐dependent IFR roughly doubled for every 10 years of age increase over 6 decades from 0.014% in children to 6.793% in octogenarians.

Conclusion

Discrepancies were found between seroprevalence and confirmed case counts. High seroprevalence rates found among Black African donors can be ascribed to historical inequities. Our IFR estimates were useful in refining previous large disagreements about the severity of the epidemic in South Africa. Blood donor‐based serosurveys provided a valuable and efficient way to provide near real‐time monitoring of the ongoing SARS‐CoV‐2 outbreak.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood DonorsCOVID-19ChildAged, 80 and overHumansSouth AfricaSARS-CoV-2Seroepidemiologic StudiesAntibodies, Viral

Stichwörter der Autor:innen

SARS-CoV-2 antibodiesblood donorsinfection fatality rateseroprevalence

Substanzen

Antibodies, Viral

Autor:innen und Institutionen

  • South African National Blood Service, Johannesburg, South Africa.
  • University of the Free State, Bloemfontein, South Africa.
  • DSI-NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa.
  • Northwestern University, Chicago, Illinois, USA.
  • Western Cape Blood Service, Cape Town, South Africa.
  • University of Johannesburg, Johannesburg, South Africa.

ORCID-Profile: Marion Vermeulen, Tanya Nadia Glatt, Karin van den Berg

Förderung

  • Centre of Excellence grant from the South African Department of Science and Innovation via the National Research Foundation
  • NIH Fogarty International Center training
  • South African National Blood Service and the Western Cape Blood Service, ELMA South Africa Foundation
  • Vitalant Research Institute, San Francisco
  • Western Cape Blood Service

Zitieren

APA

Vermeulen, M., Mhlanga, L., Sykes, W., Cable, R., Coleman, C., Pietersen, N., Swanevelder, R., Glatt, T. N., Bingham, J., van den Berg, K., Grebe, E., & Welte, A. (2024). The evolution and interpretation of seroprevalence of SARS‐CoV ‐2 antibodies among South African blood donors from the Beta to Omicron variant‐driven waves. Vox Sanguinis. https://doi.org/10.1111/vox.13571

Vancouver

Vermeulen M, Mhlanga L, Sykes W, Cable R, Coleman C, Pietersen N, et al. The evolution and interpretation of seroprevalence of SARS‐CoV ‐2 antibodies among South African blood donors from the Beta to Omicron variant‐driven waves. Vox Sanguinis. 2024. doi:10.1111/vox.13571

BibTeX
@article{Vermeulen2024,
  author = {Vermeulen, Marion and Mhlanga, Laurette and Sykes, Wendy and Cable, Russell and Coleman, Charl and Pietersen, Nadia and Swanevelder, Ronel and Glatt, Tanya Nadia and Bingham, Jeremy and van den Berg, Karin and Grebe, Eduard and Welte, Alex},
  title = {The evolution and interpretation of seroprevalence of SARS‐CoV ‐2 antibodies among South African blood donors from the Beta to Omicron variant‐driven waves},
  journal = {Vox Sanguinis},
  year = {2024},
  doi = {10.1111/vox.13571}
}
Kostenlos starten →